human | Q5 |
P496 | ORCID iD | 0000-0003-0060-1861 |
P1153 | Scopus author ID | 15764444000 |
P69 | educated at | University of Barcelona | Q219615 |
P108 | employer | Vall d'Hebron Research Institute | Q21086309 |
Sloan-Kettering Institute | Q117000887 | ||
University of Giessen | Q317053 | ||
P106 | occupation | researcher | Q1650915 |
Q37448192 | An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression |
Q38345083 | Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment. |
Q35749872 | Brush border myosin Ia has tumor suppressor activity in the intestine. |
Q54290806 | Brush border myosin Ia inactivation in gastric but not endometrial tumors. |
Q40230554 | EPHB4 and survival of colorectal cancer patients. |
Q57882192 | Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families |
Q54593908 | High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability. |
Q52945664 | Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment. |
Q92380639 | Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary |
Q37627879 | Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer. |
Q34677727 | Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR. |
Q37681807 | Loss of the EPH receptor B6 contributes to colorectal cancer metastasis |
Q50067187 | Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer |
Q35880786 | Myo5b knockout mice as a model of microvillus inclusion disease. |
Q94557838 | Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene |
Q50019986 | PHD3 controls lung cancer metastasis and resistance to EGFR inhibitors through TGFα. |
Q38938238 | PHD3 regulates EGFR internalization and signalling in tumours. |
Q89823493 | PVT1 Long Non-coding RNA in Gastrointestinal Cancer |
Q34628925 | RHOA inactivation enhances Wnt signalling and promotes colorectal cancer. |
Q112723851 | TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer |
Q39801979 | The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. |
Q38327592 | Villin expression is frequently lost in poorly differentiated colon cancer. |